Table 3.

Prognostic Factors of overall survival (OS) in patients with AML after

Variable		Survival time	Univariate		Multivariate
		Mean ± SD (Months)	HR (95% CI)	P-value	HR (95% CI)	P-value
Sex	Male	58.06 ± 6.38	0.76 (0.41-1.40)	0.38
	Female	42.97 ± 4.91	1
Age group of patients	≤ 30	52.69 ± 6.76	1.11 (0.61-2.04)	0.73
	> 30	53.98 ± 5.94	1
Diseases status at transplant	CR1	54.34 ± 4.56	0.69 (0.17-2.87)	0.61
	CR2	20.52 ± 8.71	1
WBC (×108 /ml)	<5	68.94 ± 5.82	1		1
	5-10	26.00 ± 6.8	2.97 (1.23-7.19)	0.02*	2.76 (1.13-6.72)	0.03*
	>10	22.09 ± 6.77	4.06 (1.88-8.80)	<0.001*	3.98 (1.84-8.63)	<0.001*
Donor relative	Sibling	55.91 ± 4.67	0.48(0.20-1.14)	0.09
	Related alternative	14.63 ± 4.61	1
Relapse	Yes	25.11 ± 9.45	2.61 (1.28-5.34)	0.008*	5.66 (2.6-12.34)	<0.001*
	No	57.94 ± 4.79	1		1
Age group of donors	≤ 30	58.13 ± 6.86	0.82 (0.43-1.54)	0.53
	> 30	48.15 ± 5.51	1
Sex of donor - recipient	F-F	47.70 ± 7.11	1.35 (0.58-3.14)	0.48
	F-M	59.45 ± 9.21	0.91 (0.36-2.32)	0.85
	M-F	42.27 ± 6.37	1.18 (0.51-2.73)	0.70
	M-M	57.3 ± 8.28	1
AML	M3	20.55 ± 7.49	1.15(0.28-4.76)	0.84
	Non-M3	54.00 ± 4.58	1
Different types of ALM	M2	34.62 ± 9.11	10.3 (0.13-0.68)	0.04*	0.56 (0.21-1.49)	0.25
	M4	61.24 ± 6.43	1		1
	M5	56.66 ± 7.89	0.51 (0.23-1.10)	0.09	0.72 (0.32-1.61)	0.42

Acute graft-versus-host diseases (aGVHD), chronic graft-versus-host diseases (cGVHD), first and second complete remission (CR1, CR2)